Ebola Virus (Ebola Hemorrhagic Fever) News and Research

RSS
Ebola hemorrhagic fever is a severe, often-fatal disease in humans and nonhuman primates (monkeys, gorillas, and chimpanzees) that has appeared sporadically since its initial recognition in 1976. The disease is caused by infection with Ebola virus, named after a river in the Democratic Republic of the Congo (formerly Zaire) in Africa, where it was first recognized. The virus is one of two mem bers of a family of RNA viruses called the Filoviridae. There are four identified subtypes of Ebola virus. Three of the four have caused disease in humans: Ebola-Zaire, Ebola-Sudan, and Ebola-Ivory Coast. The fourth, Ebola-Reston, has caused disease in nonhuman primates, but not in humans.
Ebola outbreak in Congo spreads to active combat zone

Ebola outbreak in Congo spreads to active combat zone

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

European Investment Bank supports Bavarian Nordic’s development of Ebola and cancer vaccines

Ebola - the implications of a worldwide epidemic

Ebola - the implications of a worldwide epidemic

Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

Promising clinical trial results for ebola vaccines

Promising clinical trial results for ebola vaccines

Weak spots in ebola’s defenses: an interview with Dr. Andrew Ward

Weak spots in ebola’s defenses: an interview with Dr. Andrew Ward

The premier Medical Support Operations summit to include speakers from AFRICOM, UK-Med and the Spanish Army

The premier Medical Support Operations summit to include speakers from AFRICOM, UK-Med and the Spanish Army

Efficacy of ebola vaccine to be assessed in large-scale clinical trial

Efficacy of ebola vaccine to be assessed in large-scale clinical trial

Experimental drug warrants clinical study for treatment of Ebola infection

Experimental drug warrants clinical study for treatment of Ebola infection

Ebola vaccine shows promising results in human trial

Ebola vaccine shows promising results in human trial

Experimental Ebola treatments to be trialled in West Africa next month

Experimental Ebola treatments to be trialled in West Africa next month

Cleaver Scientific helps in UK fight against Ebola

Cleaver Scientific helps in UK fight against Ebola

Passengers from West Africa to start 3-week Ebola screening

Passengers from West Africa to start 3-week Ebola screening

Identifying infections rapidly: an interview with Dr. David J. Ecker

Identifying infections rapidly: an interview with Dr. David J. Ecker

Ebola screening and education stepped up amid fears of spiralling epidemic

Ebola screening and education stepped up amid fears of spiralling epidemic